Xcout IntelLunai Bioworks Inc.
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Subscribe to see Lunai Bioworks Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Lunai Bioworks Inc. at a glance
Lunai Bioworks Inc. is a biotech company headquartered in Los Angeles, United States. It is publicly listed (LNAI) with a market capitalisation of $2.1M. Xcout tracks 2 named people at Lunai Bioworks Inc., including David H. Weinstein (Chief Executive Officer & Director).
Lunai Bioworks Inc. leadership
- David H. WeinsteinChief Executive Officer & Director
- Nathen FuentesChief Financial Officer
Lunai Bioworks Inc. competitors
A few of Lunai Bioworks Inc.'s closest competitors — see the full list of competitors and alternatives →
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities. Established in 2013, the company operates from its headquarters in Dallas, Texas.
Healx is an AI-native pharmaceutical company that uses artificial intelligence and technology to discover and develop new treatments for rare diseases. The company redevelops, combines, and enhances known compounds to build a drug pipeline aimed at delivering effective therapies to patients.
Auransa is a clinical-stage, AI-native biopharmaceutical company headquartered in Palo Alto, California. It utilizes a proprietary artificial intelligence platform to mine massive human disease datasets for discovering novel therapeutics.
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Monocacy Therapeutics Inc. develops artificial intelligence-guided, first-in-class immune medicines designed to restore optimal immune function and patient health. The company utilizes a full-stack, AI-powered immunology platform to discover and develop next-generation immunotherapies for patients.
LabGenius Ltd is a biotechnology company (also known as LabGenius Therapeutics) that utilizes machine learning and automation to discover and develop novel protein therapeutics. The company collaborates with major pharmaceutical partners, such as LG Chem, to advance research and development activities.
Get Lunai Bioworks Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Lunai Bioworks Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Lunai Bioworks Inc. in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access